For all our clinical trials, we believe in actively involving patients and care partners in our research and development process. This helps us understand the real-life needs and challenges that people living with cancer face.
By gaining perspectives from patients and their care partners, we can design clinical trials to reflect their needs and with
outcomes that matter to them.
We also strive to include diverse populations in our research endeavors, with representation for age, ethnicities, genders or LGBTQI+ identities, abilities and geographies, wherever possible. Medications do not always work the same for everyone, so studying outcomes in diverse patient groups can help us develop drugs that meet the needs of more patients.
Of course, with a recurrence of your lymphoma, there are many things to consider. At BeiGene, we believe it is important to realize that one of them may be participation in a clinical trial.
So, if or when your lymphoma returns, consider turning to us. If we have a study that is right for you, we’d welcome your participation.